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ABSTRACT 
 
Objectives:  To assess the variation in risk-adjusted 30-day post-operative mortality for 
colorectal cancer patients between Hospital Trusts within the English NHS. 
 
Design:  Retrospective cross sectional population-based study of data extracted from the National 
Cancer Data Repository 
 
Setting:  All providers of major colorectal cancer surgery within the English NHS  
 
Participants:  All 160,920 individuals who underwent a major resection for a colorectal cancer 
diagnosed between 1998 and 2006 in the English NHS 
 
Main outcome measures:  National patterns of 30-day post-operative mortality were examined 
and logistic binary regression used to study factors associated with death within 30 days of 
surgery. Funnel plots were used to show variation between Trusts in risk-adjusted mortality. 
 
Results:  Overall 30-day mortality was 6.7% but decreased over time from 6.8% in 1998 to 5.8% 
in 2006. The biggest reduction in mortality was seen in 2005 and 2006.  Post-operative mortality 
increased with age (15.0% (95%CI 14.1-15.9%) for those aged over 80), co-morbidity (24.2% 
(95%CI 22.0-26.5) for those with a Charlson co-morbidity score of 3 or more), stage of disease 
(9.9% (95%CI 9.3-10.6%) for Dukes’ D patients), socio-economic deprivation (7.8% (95%CI 
7.2-8.4%) for residents of the most deprived quintile) and operative urgency (14.9% (95%CI 
14.2-15.7%) for patients undergoing emergency resection). Risk-adjusted control charts 
demonstrated that one Trust had consistently significantly better outcomes and three significantly 
worse outcomes than the population mean. 
 
Conclusions:  Significant variation in 30-day post-operative mortality following major colorectal 
cancer surgery existed between NHS hospitals in England throughout the period 1998 to 2006.  
Understanding the underlying causes of this variation between surgical providers will make it 
possible to identify and spread best practice, improve outcomes and, ultimately, reduce 30-day 
post-operative mortality following colorectal cancer surgery 
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What this paper adds 
 
What is already known about this subject   
• There is increasing demand for the NHS to publish clinical outcomes, such as post-
operative mortality, to inform patient choice and improve standards.   
• To be robust and informative such figures must take into account differences in the 
casemix of patient populations, hospital surgical workloads and be population-based. 
• Previously such data have not been available. 
 
What are the new findings? 
• This study has demonstrated a method via which it is possible to assess variation in the 
risk-adjusted 30-day post-operative mortality for colorectal cancer patients across all 
hospital trusts within the English NHS.   
• The study has demonstrated significant variation in this outcome between hospital Trusts. 
 
How might it impact on clinical practice in the foreseeable future? 
• Understanding the underlying causes that have lead to the significant variation in 30-day 
post-operative mortality rates between surgical providers will make it possible to identify 
and spread best practice, improve outcomes and, ultimately, reduce post-operative 
mortality following colorectal cancer surgery 
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INTRODUCTION 
 
Colorectal cancer is the third most common cancer in the UK and, with more than 35,000 new 
cases diagnosed annually,(1) improving outcome is important. International comparisons 
demonstrate that survival from colorectal cancer in the UK is relatively poor.(2-4)  
 
Surgery is the mainstay of colorectal cancer treatment and is generally undertaken within six 
months of diagnosis. International variation in survival is greatest in this period(3) suggesting that 
differences in the quality of care may explain some of the variation. A growing body of evidence 
also indicates variation in the type and quality of treatment delivered at a national level.(5;6) 
Focussing on the best providers, understanding their successes and optimising the delivery of care 
in all hospital Trusts should, therefore, significantly improve outcomes for colorectal cancer.  
 
Institutional 30-day post-operative mortality has been suggested as one indicator of the 
effectiveness of multidisciplinary surgical care for colorectal tumours as it is clinically pertinent 
and readily understandable for the public. But reliably identifying institutions with post-operative 
mortality that could be considered ‘outlying’ (i.e. either significantly better or worse than 
average) is difficult for several reasons.(7-9) Firstly, unadjusted mortality estimates are difficult 
to interpret. Surgery inevitably carries a risk, but that risk will vary between individuals. A young 
patient, with an early-stage tumour and no co-morbid disease will bear a very different risk from 
that of an elderly, frail patient with advanced disease. Robust comparison of post-operative 
mortality between providers requires analyses to be ‘risk-adjusted’, to ensure that the impact of 
relevant differences between populations (such as patient age, co-morbidity and stage of disease) 
is taken into account. Secondly, the annual number of patients operated upon for colorectal cancer 
varies between institutions. Greater variability in post-operative mortality will arise by chance in 
institutions with smaller annual caseloads compared to units managing larger numbers. 
Appropriate adjustment for differences in hospital caseload is also vital if valid institutional 
comparisons are to be made.  
 
National risk-adjusted outcome comparisons require national data but, until now, such data have 
not been available. Numerous routine data sources exist that contains information about different 
aspects of colorectal cancer care but none contain all the data required to enable risk-adjusted 
comparisons of post-operative mortality. For example, cancer registry data(10) contains detailed 
tumour incidence and outcome information but little data on treatment. In contrast, Hospital 
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Episode Statistics(11) contains detailed treatment information but little information on the 
characteristics of the tumours. The National Cancer Intelligence Network (NCIN) has linked 
these data sources to create the National Cancer Data Repository (NCDR).(5;12) This resource 
allows the main processes and outcomes of care to be tracked for every NHS cancer patient in 
England. 
 
The NCDR contains case-mix information of reasonable quality and good data on important 
prognostic factors such as stage, age and co-morbidity. Not all the relevant data items are 
complete for each patient, however, and such missing information can restrict the interpretability 
of institutional comparisons. Techniques such as multiple imputation have the potential to 
overcome some of the problems that arise from missing data.(13;14) 
 
This study seeks to make use of the available data within the NCDR to scrutinise risk-adjusted 
surgical outcomes for colorectal cancer patients at a population level. It seeks to monitor national 
patterns and trends of 30-day post-operative mortality following major resection of colorectal 
cancer and, using multiple imputation(13;14) and funnel plots,(8;9) to produce robust 
comparisons of the performance of all NHS Hospital Trusts in England. 
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METHODS 
 
The National Cancer Data Repository (NCDR) consists of pooled data from the eight population-
based cancer registries that cover England, linked (using all or combinations of the identifiers of 
NHS number, date of birth, postcode at diagnosis and sex) to an extract of Hospital Episode 
Statistics (HES) including episodes of in-patient care for individuals who presented in any NHS 
hospital with a diagnostic code for cancer between April 1997 and June 2007. 
 
Information was extracted from this resource on all individuals who underwent a major resection 
for a primary colorectal cancer diagnosed between 1 January 1998 and 31 December 2006. 
Information on age, sex, Dukes’ stage, NHS number, postcode at diagnosis, dates of diagnosis 
and, where relevant, date of death, was extracted  from the registry dataset for all colorectal 
cancers (ICD10(15) C18-C20) whilst information about patient management was derived from 
HES. For each colorectal cancer patient in the registry extract who could be linked to the HES 
dataset all in-patient episodes of care were searched to identify the date of the first major surgical 
resection for colorectal disease after diagnosis. Major colorectal resections  were identified by 
OPCS4 codes(16;17) for emergency excision of appendix (H01); excision of appendix (H02); 
panproctocolectomy (H041); total colectomy (H05); extended right hemicolectomy (H06); right 
hemicolectomy (H07); transverse colectomy (H08); left hemicolectomy (H09); sigmoid 
colectomy (H10); colectomy (H11); sub-total colectomy (H29); excision of rectum (H33) and 
total exenteration of pelvis (X14). Information about the hospital Trust and the Cancer Network 
in which the patient was managed were derived from this episode of care. If a patient underwent 
two or more major colorectal resections during different episodes of treatment, the first operation 
was used. If a patient underwent two or more procedures during the same episode, the most 
radical or extensive procedure was used.  
 
A Charlson co-morbidity score was calculated for each individual based on the diagnostic codes 
(excluding cancer) recorded for any hospital admissions in the year prior to diagnosis of their 
colorectal tumour, excluding any admission spanning the period of diagnosis. The cancer 
component of the Charlson index was derived for each patient from the cancer registry 
information in the NCDR. The score for any cancers diagnosed in the year before diagnosis of the 
colorectal tumour was added to scores obtained from the HES data. Higher scores indicate greater 
co-morbid disease. Patients were grouped into Charlson score categories of 0, 1, 2 and 3 or 
greater. 
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The urgency of surgery has been shown to have a strong influence on the risk of post-operative 
death(18) but this information is not recorded in HES. The method of admission is, however, 
available. Patients who were admitted as an emergency and underwent surgery within two days of 
admission were, therefore, deemed to have undergone emergency surgery while all others were 
considered elective. 
 
30-day post-operative mortality (the percentage of patients dead within 30 days of surgery) was 
calculated for each year of diagnosis, age group, sex, Dukes’ stage of the primary tumour at 
diagnosis, quintile of the income domain of the Index of Multiple Deprivation 2004 (derived from 
each patient’s postcode of residence at diagnosis allocated into lower super output areas), 
Charlson score and Cancer Network and Trust in which the initial colorectal resection occurred. 
The statistical significance of any differences in post-operative mortality was assessed using the 
χ
2 test.  
 
Of the 160,920 cases, Dukes’ stage was missing in 24,434 (15.2%) because the information had 
not been captured by the cancer registry while the IMD income domain score could not be 
derived for 404 (0.25%) because of incomplete postcode information. Analysis restricted to 
patients with complete data would have allowed post-operative mortality to be assessed in 
136,105 (84.6%) patients, preventing Trust-level comparisons. Such estimates would also be at 
risk of bias with inflated standard errors. Missing data for Dukes’ stage and IMD income category  
were imputed deterministically using the ‘ICE’(19) command in Stata (version 11) with passive 
and substitute options and ordered logistic regression for five imputations and 10 cycles of 
regression switching. It was assumed that the data were ‘missing at random’ (MAR). Dukes’ 
stage is MAR if, given fully observed variables, the chance of Dukes’ stage being missing does 
not depend on the value of Dukes’ stage. This assumption is made plausible because a wide range 
of variables were included in the imputation model, including all variables used in the analysis, 
all variables predictive of missing values and all variables influencing the process causing the 
missing data.(13) The imputation model consisted of post-operative mortality within 30 days of 
surgery, age at diagnosis, sex, median annual workload of the Trust, Dukes’ stage, IMD income 
quintile, resection type (emergency or elective), admission type (emergency or elective), year of 
diagnosis, year of operation, Charlson co-morbidity score, site of the initial primary, hospital trust 
and cancer registry. For comparative purposes the models used to investigate post-operative 
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mortality were built using both the imputed dataset and a dataset restricted to cases with complete 
data. 
 
Multilevel (random effects) binary logistic regression models were built to determine the factors 
associated with death within 30 days of surgery. The models were built with a hierarchy of 
patients clustered within hospital trusts (level 2), within cancer networks (level 3) so allowing for 
correlations between patient outcomes. The dependent variable, death within 30 days of surgery, 
was considered as a binary outcome. Covariates (explanatory variables) in the risk-adjusted 
model included age (per year increase), sex, site of the initial colorectal primary, IMD income 
quintile, year of diagnosis, Dukes’ stage at diagnosis, Charlson co-morbidity score and resection 
type (elective or emergency). Separate analyses were undertaken for patients diagnosed during 
1998-2002 and 2003-2006. 
 
Funnel plots were used to compare 30-day mortality rates between hospital Trusts in each time 
period according to Speigelhalter’s method.(9) Trust-specific mortality ratios were calculated 
from each individual’s probability of death within 30 days of surgery derived from the model 
based on the imputed dataset.  Trust-specific risk-adjusted mortality rates were subsequently 
calculated by multiplying the Trust-specific mortality ratios by the average national post-
operative mortality rate (‘the target’ shown on the funnel plot as a red horizontal line). Trust 
mortality rates were then plotted against the Trust workload using the ‘funnelcompar’ command 
in Stata with 95% and 99.8% control limits (the inner and outer grey dashed lines respectively on 
the charts) around the target (the national 30-day post-operative rate represented as the red line on 
the chart). Hospital Trusts for which the 30-day post-operative mortality rate was more than three 
standard deviations from the national figure (i.e. outside the 99.8% control limits) were 
considered to be outliers.
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RESULTS 
 
160,920 individuals were identified with a diagnosis of colorectal cancer between 1998 and 2006 
and who subsequently underwent a major resection for their disease.  They were treated in 150 
different hospital Trusts within 28 Cancer Networks.  Of these 10,704 (6.7%) died within 30 days 
of the resection. Characteristics of the study population are presented in Table 1.  The distribution 
of stage before and after imputation and amongst the imputed cases was very similar (Table 2). 
 
Table 1 shows the characteristics of the population and their relationship to 30-day post-operative 
mortality.  Due to the high numbers of individuals included in the study the majority of the 
differences across groups are statistically significant.  Analyses undertaken on the imputed dataset 
and accounting for the clustering of patients with Trusts demonstrated that the 30-day post-
operative mortality declined slightly from 6.9% (95% Confidence Interval (CI) 6.3-7.5%) in 1998 
to 5.9% (95%CI 5.4-6.4%) in 2006. Women were significantly less likely to die post-operatively 
than men (6.5% (95%CI 6.1-6.9%) vs. 6.8% (95%CI 6.4-7.3%). Post-operative mortality was 
significantly associated with age: 1.2% (95%CI 1.0-1.4%) of patients operated upon under the 
age of 50 died within 30 days of surgery compared to 15.0% (95%CI 14.1-15.9%) of those over 
80. Post-operative mortality was increased with more advanced tumour stage (4.2% (95%CI 3.7-
4.7%) for Dukes’ A tumours vs. 9.9% (95%CI 9.3-10.6%) for Dukes’ D tumours, greater socio-
economic deprivation (5.7% (95%CI 5.3-6.1%) in the most affluent vs. 7.8% (95%CI 7.2-8.4%) 
in the most deprived) and greater co-morbidity (5.4% (95%CI 5.0-5.7%) for Charlson score zero 
vs. 24.2% (95%CI 22.0-26.5%) for score 3 or more). Patients with colonic tumours had higher 
post-operative mortality than those with rectal tumours (7.7% (95%CI 7.3-8.2%) vs. 4.6% 
(95%CI 4.3-5.0%)). Operative urgency was also important: 14.9% (95%CI 14.2-15.7%) of 
patients operated as an emergency died within 30 days of surgery, compared with only 5.8% 
(95%CI 5.4-6.2%) of those operated upon electively. 
 
Results of multivariable analyses examining the adjusted odds of death within 30 days of surgery 
are shown in Table 3. The odds of death were significantly higher for each successive decade of 
age (odds ratio (OR) 1.08 for each year increase in age, 95% confidence interval (CI) 1.08-1.08, 
p<0.001), Dukes’ stage (OR 2.50, 95%CI 2.24-2.78 for Dukes’ D vs. Dukes’ A, p<0.001), 
deprivation (OR 1.32, 95%CI 1.23-1.42 for the most deprived vs. the most affluent, p<0.001), co-
morbidity (OR 4.38, 95%CI 3.98-4.82 for Charlson co-morbidity score of 3 vs. zero, p<0.001) 
and those operated upon as an emergency (OR 2.67, 95%CI 2.53-2.82, p<0.001). The odds of 
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death were lower in women than men (OR 0.83, 95%CI 0.79-0.86) and lower for patients with 
rectal tumours than those with colonic tumours (OR 0.94, 95% 0.89-0.99). 
 
The odds of death within 30 days of surgery for the various case-mix factors are shown in Table 
4.  A strong deprivation effect was apparent even after adjustment for the case-mix factors 
thought to differ between socio-economic groups such as stage, co-morbidity and emergency 
presentation. 
 
For patients diagnosed during 1998-2002, unadjusted 30-day post-operative mortality was above 
the 99.8% control limit for eight Trusts (Figure 1A), indicating that their surgical mortality was 
significantly higher than expected. A further 20 Trusts were above the 95% control limit. After 
inclusion of all risk factors in the model (Figure 1B) eight Trusts remained above the upper 
99.8% limit while 15 Trusts were above the 95% control limit. Six Trusts had significantly lower 
30-day post-operative mortality than could be explained by the available case-mix information 
(i.e. they were below the lowest 99.8% control limit) and 19 more Trusts were below the 95% 
control limit. In the risk-adjusted model, five and 17 Trusts respectively remained below the 
lower 99.8% and 95% control limits. 
 
Similar results were observed for patients diagnosed during 2003-2006 (Figure 2). In the risk-
adjusted model, post-operative mortality in five Trusts was above the upper 99.8% control limit 
whilst a further 11 were above the 95% limit. Three Trusts had significantly better outcomes than 
expected, below the 99.8% limit, and nine Trusts were below the 95% limit. 
 
Three trusts appeared above (and one Trust below) the 99.8% control limits in both time periods 
indicating consistently outlying 30-day post-operative mortality. 
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DISCUSSION 
 
This retrospective population-based study is the first to provide a comprehensive, national 
perspective on the 30-day post-operative mortality associated with colorectal cancer surgery 
across England. Overall, 6.7% of the study population died within 30 days of surgery amounting 
to 10,704 deaths. There was significant variation across the population with post-operative 
mortality greater in the elderly, men, the socio-economically deprived, those with advanced stage 
disease at diagnosis or with additional co-morbidities and amongst those operated upon as an 
emergency. Significant variation, independent of case-mix, was also observed between hospital 
Trusts. One Trust had post-operative mortality significantly lower and three significantly higher 
than could be explained by the case-mix information available in both time periods examined.  
These hospitals were all District General Hospitals and two of those with significantly worse 
outcomes than expected had Foundation status. 
 
The post-operative mortality of 6.7% seen in this study is notably higher than that previously 
reported for the UK. Data submitted to the most recent National Bowel Cancer Audit Programme 
(NBOCAP) report recorded post-operative mortality of 4.7% for all surgical cases.(5) Submission 
to this audit is, however, voluntary resulting in incomplete case ascertainment. In addition, it is 
not possible to calculate post-operative mortality across all surgically resected cases submitted 
due to incomplete or inaccurate reporting of dates of surgery and (prior to 2009) death. In 
consequence, it is likely that, due to under-reporting, the results from the NBOCAP audits are 
biased. 
 
The post-operative mortality of English colorectal cancer patients determined in this study is also 
significantly higher than that reported from other countries. 30-day post-operative mortality from 
population-based studies in Scandinavia, Canada and the USA ranged from 2.7% (for rectal 
cancers alone) to 5.7%.(20-25) Whilst there are undoubtedly big differences between the 
populations in these international studies that make comparison to the UK difficult, the post-
operative mortality from these reports are consistently below the 6.7% found in this study. This 
suggests that either the NHS may have fundamentally worse post-operative outcomes than some 
other comparable health services or the operative risk of patients differs between countries. 
Understanding and minimising these differences could significantly reduce the number of 
premature deaths caused by this disease across the country. 
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A strong relationship between socio-economic deprivation and post-operative mortality was 
observed with those who resided in more deprived areas having significantly greater risk of death 
within 30 days of surgery than those who resided in more affluent areas.  This effect remained 
despite adjustment for stage of disease, co-morbidity and urgency of surgical resection.  This 
finding mirrors other studies that have shown socio-economic gradients in both the long and 
short-term outcomes of colorectal cancer.(22;26;27) In contrast, there is evidence to suggest that 
in a randomised trial setting where patients were given equal treatment this gradient 
disappeared(28)  although it is possible this may be partially explained by the participants of 
randomised trials being of a better prognosis than those who are not.  Further evidence is 
required, therefore, before it is possible to determine whether inequalities in care may account for 
some of the socio-economic disparities observed in 30-day post-operative mortality.  
Understanding the causes of the gradient and minimising it has the potential, however, to 
significantly improve outcomes from colorectal cancer. 
 
A limitation of this study is that is based on routine health data in the form of  linked routine 
cancer registry and HES and the quality and accuracy of coding within these resources has been 
questioned.(29) A recent study, however, identified colorectal cancer patients enrolled in a 
randomised trial within the NCDR and found excellent agreement in the information recorded in 
both datasets with regard to both treatment and outcomes.(30) This demonstrated that the data 
within the NCDR were sufficient to monitor 30-day post-operative mortality across the country.  
 
Another potential limitation of the study is that the case-mix adjustment was inadequate due to 
the routine nature of the data upon which it was based. The NCDR does not contain detailed 
information about every aspect of a patient or their care that could influence the risk of post-
operative death and, in consequence, it is possible that some unmeasured prognostic factor is 
confounding our results. These analyses do, however, include adjustment for many of the most 
important factors known to influence outcome such as age, co-morbidity, stage of disease and 
socio-economic deprivation and, as such, the results should not be dismissed. Previous studies 
have demonstrated that routine data can be used to identify divergent practice(31;32) and the 
linked data upon which this study is based are much more comprehensive than any previously 
available. Furthermore, it is hoped that the NBOCAP data will soon be incorporated into the 
NCDR. These data contain information such as anaesthetic risk scores that are not currently 
available in the NCDR but that could significantly influence post-operative outcomes. The 
availability of such data could, in the future, help refine the models further. 
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Currently, the NCDR is limited by the timeliness of the routine data available. Efforts are being 
made across the NHS to increase the timeliness of data it collects and it is a priority for the NCIN 
to improve the temporality of the NCDR. In the future, therefore, it is hoped that timelier 
reporting can be achieved.  
 
Many factors may influence 30-day post-operative mortality.  These may relate to the patient (for 
example, stage of disease or level of co-morbidity) or the institution offering care (such as the 
specialisation of the operating team, the quality of post-operative care or the availability of beds 
in high dependency and intensive care units).  Examining how these factors vary in relation to 30-
day post-operative mortality rates may provide evidence to help explain the variability seen 
across English NHS Trusts, amongst socio-economic groups and between countries.  Whilst this 
study has identified providers with outlying 30-day post-operative mortality, however, it is not 
possible to determine from the data available what aspects of care or, indeed, if the quality of care 
within these units is deficient. The outlying status could be explained by problems in data quality, 
chance or, as discussed previously, case-mix factors not quantified in this study. Institutions with 
outlying status should not, however, be ignored but efforts made to determine why they appear to 
have significantly better or worse post-operative mortality than other units. With this information 
it should then be possible to learn from those achieving good outcomes, by seeking the 
underlying causes, adding to and spreading the adoption of best practice guidelines,(33-36) 
improving poor outcomes and, ultimately, reducing post-operative mortality following colorectal 
cancer surgery. 
 
The UK’s cardiothoracic surgeons have openly reported their surgical outcomes since 1998 and 
the publication of these results have demonstrably improved outcomes for cardiothoracic surgical 
mortality across the country.(37;38) It is intended that the development of the NCDR will enable 
national 30-day post-operative mortality to be reported annually at both a Trust and (as the NCDR 
also contains information about the consultant overseeing each surgical event), potentially, 
surgeon level (although it should be emphasised that post-operative mortality should be treated as 
a colorectal team or Trust event and the operating surgeon should not be vilified).  The NCIN 
plans to work collaboratively with the Association of Coloproctology of Great Britain and Ireland 
(ACPGBI), therefore, to disseminate these findings to hospital Trusts and Cancer Networks and 
use them to inform care. The reduction in 30-day post-operative mortality over the study period is 
welcomed but our findings show that there was wide variation across the NHS and considerable 
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scope for improvement. It is now time for colorectal cancer, and subsequently other cancer teams, 
to follow the cardiothoracic example in order to improve outcomes.  The NCDR provides the 
means by which this process can start. 
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FIGURES & TABLES 
Table 1: Characteristics of the study population 
 
Dead within 30 days of surgery 
Overall  Multilevel 
Characteristic Total n %  % (95%CI) 
≤50 9,552 112 1.2  1.2 (1.0 , 1.4) 
51-60 22,436 438 2  1.9 (1.7 , 2.2) 
61-70 43,695 1,669 3.8  3.9 (3.5 , 4.2) 
71-80 57,373 4,344 7.6  7.6 (7.1 , 8) 
Age >80 27,864 4,141 15  15.0 (14.1 , 15.9) 
Male 88,789 6,037 6.8  6.8 (6.4 , 7.3) 
Sex Female 72,131 4,667 6.5  6.5 (6.1 , 6.9) 
1998 18,018 1,231 6.8  6.9 (6.3 , 7.5) 
1999 18,076 1,276 7.1  7.1 (6.5 , 7.7) 
2000 18,075 1,249 6.9  6.9 (6.4 , 7.5) 
2001 17,296 1,195 6.9  6.9 (6.4 , 7.5) 
2002 17,336 1,213 7  7.0 (6.5 , 7.5) 
2003 17,498 1,155 6.6  6.6 (6 , 7.1) 
2004 17,869 1,230 6.9  6.9 (6.4 , 7.4) 
2005 18,421 1,086 5.9  6.0 (5.5 , 6.4) 
Year of diagnosis 2006 18,331 1,069 5.8  5.9 (5.4 , 6.4) 
Colon 104,023 7,933 7.6  7.7 (7.3 , 8.2) 
Rectosigmoid 13,555 748 5.5  5.6 (5.1 , 6.2) 
Cancer site Rectum 43,342 2,023 4.7  4.6 (4.3 , 5) 
0 137,924 7,333 5.3  5.4 (5.0 , 5.7) 
1 13,618 1,754 13  13.1 (12.2 , 14.1) 
2 6,551 946 14  14.7 (13.2 , 16.3) 
Charlson co-morbidity score ≥3 2,827 671 24  24.2 (22.0 , 26.5) 
A 17,151 606 3.5  4.2 (3.7 , 4.7) 
B 53,711 3,122 5.8  6.2 (5.8 , 6.6) 
C 51,390 3,247 6.3  7.1 (6.7 , 7.6) 
D 14,234 1,287 9  9.9 (9.3 , 10.6) 
Dukes’ stage Unknown 24,434 2,442 10  - - 
Most affluent 31,538 1,790 5.7  5.7 (5.3 , 6.1) 
2 35,139 2,113 6  6.0 (5.5 , 6.5) 
3 34,409 2,320 6.7  6.8 (6.4 , 7.2) 
4 31,889 2,358 7.4  7.3 (6.9 , 7.8) 
Most deprived 27,541 2,122 7.7  7.8 (7.2 , 8.4) 
IMD income category Unknown 404 1 0.2  - - 
Elective 145,480 8,401 5.8  5.8 (5.4 , 6.2) 
Operation type Emergency 15,440 2,303 15  14.9 (14.2 , 15.7) 
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Table 2 Dukes’ stage distribution by co-variable category, and before and after imputation 
 
Stage at diagnosis Characteristic 
A B C D Unknown 
≤50 9.4 25.7 33.8 12.8 18.2 
51 to 60 11.0 28.3 33.8 11.2 15.7 
61 to 70 11.4 31.2 32.6 9.4 15.4 
71 to 80 11.0 35.3 31.1 8.2 14.6 
Age at diagnosis 
≥81 9.0 39.7 30.5 6.1 14.7 
Male 11.1 32.9 31.7 8.8 15.5 Sex 
Female 10.1 34.0 32.2 8.9 14.9 
Elective 11.6 33.5 31.4 8.3 15.2 Operation 
Emergency 1.8 31.9 37.3 14.2 14.8 
1 11.5 32.3 32.0 8.7 15.5 
2 11.2 33.3 32.1 8.6 14.8 
3 10.4 34.2 31.8 8.7 14.9 
4 10.2 33.5 32.0 8.8 15.6 
5 9.8 33.5 31.7 9.7 15.4 
IMD income category 
Unknown1 11.4 34.7 36.6 11.6 5.7 
Colon 7.6 36.7 32.1 9.9 13.6 
Rectosigmoid 11.8 30.7 33.3 10.0 14.3 Cancer site 
Rectum 17.6 26.3 31.0 6.0 19.2 
1998 8.5 31.0 28.2 8.6 23.7 
1999 10.1 30.9 30.3 8.9 19.9 
2000 10.4 33.1 31.8 8.8 15.9 
2001 11.3 34.7 32.8 9.9 11.4 
2002 10.9 34.5 34.2 9.2 11.2 
2003 11.2 33.9 32.6 8.7 13.6 
2004 10.4 31.8 30.4 8.4 19.0 
2005 11.5 35.1 34.5 8.7 10.2 
Year of diagnosis 
2006 11.8 35.5 32.6 8.4 11.7 
0 10.9 33.1 31.8 9.0 15.3 
1 8.2 34.7 33.7 8.7 14.7 
2 10.6 35.5 31.9 7.6 14.5 
Charlson co-morbidity score 
3 9.2 37.4 31.9 6.1 15.5 
       
Before imputation (all) 10.7 33.4 31.9 8.9 15.2 
Before imputation (staged cases only) 12.6 39.4 37.7 10.4 - 
After imputation 12.7 39.5 37.4 10.4 - 
Dukes’ stage distribution 
Across imputed cases 13.5 40.0 36.3 10.1 - 
 
 
                                                     
1
 IMD income category information was missing in only a small proportion of cases (n=404, 0.25%) 
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Table 3: Multivariable analyses showing the odds of death within 30 days of surgery  
 
Complete case analysis2 Multiple imputation analysis3 
Characteristic 
OR 95% CI P-value OR 95% CI P-value 
Age at diagnosis (per year) 1.08 (1.07, 1.08) <0.001 1.08 (1.08, 1.08) <0.001 
Year of diagnosis (per advancing year) 0.99 (0.98, 1.00) <0.001 0.97 (0.97, 0.98) <0.001 
Male 1.00 - 1.00 - Sex 
Female 0.81 (0.77, 0.85) <0.001 0.83 (0.79, 0.86) <0.001 
Elective 1.00 - 1.00 - Operation 
Emergency 2.61 (2.46, 2.77) <0.001 2.67 (2.53, 2.82) <0.001 
A 1.00 - 1.00 - 
B 1.28 (1.17, 1.4) 1.23 (1.12, 1.35) 
C 1.53 (1.39, 1.68) 1.54 (1.40, 1.69) 
Dukes’ stage at 
diagnosis 
D 2.63 (2.37, 2.93) 
<0.001 
2.50 (2.24, 2.78) 
<0.001 
Most affluent 1.00 - 1.00 - 
2 1.04 (0.96, 1.12) 1.03 (0.96, 1.10) 
3 1.13 (1.05, 1.22) 1.11 (1.04, 1.19) 
4 1.24 (1.15, 1.34) 1.22 (1.13, 1.30) 
IMD income category 
Most deprived 1.37 (1.26, 1.49) 
<0.001 
1.32 (1.23, 1.42) 
<0.001 
Colon 1.00 - 1.00 - 
Rectosigmoid 0.83 (0.76, 0.91) 0.88 (0.82, 0.96) Cancer site 
Rectum 0.92 (0.86, 0.98) 
<0.001 
0.94 (0.89, 0.99) 
0.0021 
0 1.00 - 1.00 - 
1 2.12 (1.99, 2.26) 2.05 (1.94, 2.18) 
2 2.46 (2.26, 2.68) 2.43 (2.25, 2.62) 
Charlson co-morbidity 
score 
≥3 4.51 (4.06, 5.01) 
<0.001 
4.38 (3.98, 4.82) 
<0.001 
 
                                                     
2
 Analyses based on only those individuals for whom all casemix variables were available (n=136,105) 
3
 Analyses based on all individuals with missing casemix data being imputed (n=160,290) 
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Table 4: The results of the additive logistic regression models (based on the imputed dataset) investigating the odds of death within 30 days of surgery 
 
Characteristic  OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Age at diagnosis (per year) 1.08 1.08 - 1.08 1.08 1.07 - 1.08 1.08 1.08 - 1.08 1.08 1.08 - 1.08 
Sex Male 1.00 - 1.00 - 1.00 - 1.00 - 
 Female 0.78 0.75 - 0.81 0.82 0.79 - 0.86 0.82 0.79 - 0.86 0.83 0.79 - 0.86 
Year of diagnosis  0.98 0.97 - 0.98 0.97 0.96 - 0.98 0.97 0.96 - 0.98 0.97 0.97 - 0.98 
Cancer site Colon 1.00 - 1.00 - 1.00 - 1.00 - 
 Rectosigmoid 0.77 0.71 - 0.84 0.82 0.76 - 0.89 0.83 0.76 - 0.9 0.88 0.82 - 0.96 
 Rectum 0.7 0.67 - 0.74 0.77 0.73 - 0.81 0.82 0.78 - 0.86 0.94 0.89 - 0.99 
IMD income category Most affluent 1.00 - 1.00 - 1.00 - 1.00 - 
 2 1.03 0.97 - 1.11 1.03 0.96 - 1.1 1.03 0.96 - 1.1 1.03 0.96 - 1.10 
 3 1.14 1.07 - 1.22 1.12 1.05 - 1.2 1.12 1.05 - 1.2 1.11 1.04 - 1.19 
 4 1.26 1.18 - 1.35 1.22 1.14 - 1.31 1.22 1.14 - 1.31 1.22 1.13 - 1.30 
 Most deprived 1.42 1.32 - 1.52 1.35 1.26 - 1.45 1.35 1.25 - 1.45 1.32 1.23 - 1.42 
Charlson score 0   1.00 - 1.00 - 1.00 - 
 1   2.04 1.93 - 2.16 2.02 1.91 - 2.14 2.05 1.94 - 2.18 
 2   2.34 2.17 - 2.53 2.38 2.2 - 2.56 2.43 2.25 - 2.62 
 ≥3   4.13 3.76 - 4.54 4.23 3.85 - 4.65 4.38 3.98 - 4.82 
Dukes’ stage A     1.00 - 1.00 - 
 B     1.31 1.2 - 1.44 1.23 1.12 - 1.35 
 C     1.7 1.55 - 1.87 1.54 1.40 - 1.69 
 D     2.86 2.57 - 3.19 2.50 2.24 - 2.78 
Operation type Elective       1.00 - 
 Emergency       2.67 2.53 - 2.82 
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